5 August 2020 in Cancer Gene Therapy
1 February 2016 in American Journal of Physiology-Cell Physiology
Recent studies have shown that activation of liver X receptors (LXRs) attenuates the development of atherosclerosis, not only by regulating lipid metabolism but also by suppressing inflammatory signaling. Sphingosine 1-phosphate receptor 2 (S1PR2), an important inflammatory gene product, plays a role in the development of various inflammatory diseases. It was proposed that S1PR2 might be regulated by LXR-α. In the present study, the effect of LXR-α on tumor necrosis factor-α (TNF-α)-induced S1PR2 expression in human umbilical vein endothelial cells (HUVECs) was investigated and the underlying mechanism was explored. The results demonstrated that TNF-α led to an increase in S1PR2 expression and triggered a downregulation of LXR-α expression in HUVECs as well. Downregulation of LXR-α with specific small interfering RNA (siRNA) remarkably enhanced the primary as well as TNF-α-induced expression of S1PR2 in HUVECs. Activation of LXR-α by agonist GW3965 inhibited both primary and TNF-α-induced S1PR2 expression. GW3965 also attenuated S1PR2-induced endothelial barrier dysfunction. The data further showed that TNF-α induced a significant decrease in miR-130a-3p expression. Overexpression of miR-130a-3p with mimic product reduced S1PR2 protein expression, and inhibition of miR-130a-3p by specific inhibitor resulted in an increase in S1PR2 protein expression. Furthermore, activation of LXRs with agonist enhanced the expression of miR-130a-3p, and knockdown of LXR-α by siRNA suppressed miR-130a-3p expression. These results suggest that LXR-α might downregulate S1PR2 expression via miR-130a-3p in quiescent HUVECs. Stimulation of TNF-α attenuates the activity of LXR-α and results in enhanced S1PR2 expression.
1 September 2026 in Journal of Hepatocellular Carcinoma
Purpose: This study aims to screen key miRNA/mRNA axes associated with hepatocellular carcinoma (HCC), and then conduct functional validation and mechanistic exploration, thereby offering novel clues for screening HCC-targeted therapeutic candidates. Methods: Bioinformatics analysis was performed to identify key HCC-related miRNA/mRNA axes. The direct interaction between hsa-miR-139-5p and centromere protein M (CENPM) was verified via a dual-luciferase reporter (DLR) assay. We carried out colony formation, Transwell and in vivo xenograft assays to validate the biological functions of the hsa-miR-139-5p/CENPM axis. The underlying mechanism of this axis was further explored via in vitro cellular experiments. The Cancer Genome Atlas Liver Hepatocellular Carcinoma (TCGA-LIHC) cohort was used for prognostic evaluation of this axis. Results: Six key HCC-related miRNA/mRNA regulatory axes were screened out. The hsa-miR-139-5p/CENPM axis was selected for further validation. DLR assay confirmed that hsa-miR-139-5p directly targeted CENPM. Sole overexpression of hsa-miR-139-5p significantly downregulated CENPM protein levels, and suppressed in vitro cell colony formation, migration and invasion, as well as in vivo growth of subcutaneous HCC xenografts. Notably, simultaneous overexpression of CENPM could fully rescue the tumor-suppressive phenotypes induced by hsa-miR-139-5p overexpression. In contrast, sole overexpression of CENPM markedly promoted HCC cell malignant behaviors and subcutaneous xenograft growth, while concurrent transfection of hsa-miR-139-5p could attenuate these oncogenic effects driven by CENPM overexpression. Mechanistically, hsa-miR-139-5p restrained the activation of the Akt/mTOR pathway and inhibited nuclear translocation of β-catenin to suppress epithelial-mesenchymal transition (EMT) by targeting CENPM in HCC cells. The hsa-miR-139-5phigh/CENPMlow subgroup had significantly better survival outcomes than the hsa-miR-139-5plow/CENPMhigh subgroup. Conclusion: hsa-miR-139-5p targeted CENPM to suppress EMT and malignant progression of HCC via regulating the Akt/mTOR pathway and β-catenin nuclear translocation. The combined expression pattern of hsa-miR-139-5p and CENPM correlated significantly with HCC patient prognosis. Our findings offer new evidence for HCC prognostic stratification and targeted intervention candidate screening.